Debate: Statins should be used in patients with heart failure
Treatment to prevent progression of heart failure has been targeted to reverse the consequences of heart failure and to a lesser extent the cause – the atherosclerotic plaque itself. Less than 50% of patients with heart failure are treated with lipid intervention. Heart failure (New York Heart Assoc...
Uloženo v:
| Vydáno v: | Curr Control Trials Cardiovasc Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64828/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806812/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-6-268 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|